These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 17627937)
21. Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19. Zhou M; Wang X; Phung V; Lindhout DA; Mondal K; Hsu JY; Yang H; Humphrey M; Ding X; Arora T; Learned RM; DePaoli AM; Tian H; Ling L Cancer Res; 2014 Jun; 74(12):3306-16. PubMed ID: 24728076 [TBL] [Abstract][Full Text] [Related]
22. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho. Aaldijk AS; Verzijl CRC; Jonker JW; Struik D Front Endocrinol (Lausanne); 2023; 14():1150222. PubMed ID: 37260446 [TBL] [Abstract][Full Text] [Related]
23. The Klotho gene family and the endocrine fibroblast growth factors. Kurosu H; Kuro-o M Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672 [TBL] [Abstract][Full Text] [Related]
24. Making way for suppressing the FGF19/FGFR4 axis in cancer. Prieto-Dominguez N; Shull AY; Teng Y Future Med Chem; 2018 Oct; 10(20):2457-2470. PubMed ID: 30325210 [TBL] [Abstract][Full Text] [Related]
25. FGF19-FGFR4 signaling elaborates lens induction with the FGF8-L-Maf cascade in the chick embryo. Kurose H; Okamoto M; Shimizu M; Bito T; Marcelle C; Noji S; Ohuchi H Dev Growth Differ; 2005 May; 47(4):213-23. PubMed ID: 15921496 [TBL] [Abstract][Full Text] [Related]
26. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. Wu X; Ge H; Lemon B; Vonderfecht S; Weiszmann J; Hecht R; Gupte J; Hager T; Wang Z; Lindberg R; Li Y J Biol Chem; 2010 Feb; 285(8):5165-70. PubMed ID: 20018895 [TBL] [Abstract][Full Text] [Related]
27. Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma. Poh W; Wong W; Ong H; Aung MO; Lim SG; Chua BT; Ho HK Mol Cancer; 2012 Mar; 11():14. PubMed ID: 22439738 [TBL] [Abstract][Full Text] [Related]
28. β-Klotho gene variation is associated with liver damage in children with NAFLD. Dongiovanni P; Crudele A; Panera N; Romito I; Meroni M; De Stefanis C; Palma A; Comparcola D; Fracanzani AL; Miele L; Valenti L; Nobili V; Alisi A J Hepatol; 2020 Mar; 72(3):411-419. PubMed ID: 31655133 [TBL] [Abstract][Full Text] [Related]
29. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression. Feng S; Dakhova O; Creighton CJ; Ittmann M Cancer Res; 2013 Apr; 73(8):2551-62. PubMed ID: 23440425 [TBL] [Abstract][Full Text] [Related]
30. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Kurosu H; Kuro-O M Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940 [TBL] [Abstract][Full Text] [Related]
31. Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis. Alvarez-Sola G; Uriarte I; Latasa MU; Urtasun R; Bárcena-Varela M; Elizalde M; Jiménez M; Rodriguez-Ortigosa CM; Corrales FJ; Fernández-Barrena MG; Berasain C; Avila MA Dig Dis; 2017; 35(3):158-165. PubMed ID: 28249259 [TBL] [Abstract][Full Text] [Related]
32. Fundamentals of FGF19 & FGF21 action in vitro and in vivo. Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463 [TBL] [Abstract][Full Text] [Related]
33. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467 [TBL] [Abstract][Full Text] [Related]
34. Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma. Li Y; Zhang W; Doughtie A; Cui G; Li X; Pandit H; Yang Y; Li S; Martin R Oncotarget; 2016 Aug; 7(32):52329-52339. PubMed ID: 27447573 [TBL] [Abstract][Full Text] [Related]
35. FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression. Zhao X; Xu F; Dominguez NP; Xiong Y; Xiong Z; Peng H; Shay C; Teng Y Mol Carcinog; 2018 Nov; 57(11):1616-1625. PubMed ID: 30074276 [TBL] [Abstract][Full Text] [Related]
37. FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis. Lang L; Xiong Y; Prieto-Dominguez N; Loveless R; Jensen C; Shay C; Teng Y J Exp Clin Cancer Res; 2021 Mar; 40(1):93. PubMed ID: 33691750 [TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer. Hu L; Cong L Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668 [TBL] [Abstract][Full Text] [Related]
39. Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma. Yoo C; Kang J; Kim D; Kim KP; Ryoo BY; Hong SM; Hwang JJ; Jeong SY; Hwang S; Kim KH; Lee YJ; Hoeflich KP; Schmidt-Kittler O; Miller S; Choi EK Oncotarget; 2017 Jun; 8(24):38592-38601. PubMed ID: 28445152 [TBL] [Abstract][Full Text] [Related]
40. Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis. Wu X; Li Y Aging (Albany NY); 2009 Dec; 1(12):1023-7. PubMed ID: 20157585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]